A Phase 1 study of the safety, tolerability, and pharmacokinetics of ALG-000184 (pevifoscorvir sodium), a novel Class E capsid assembly modulator, in healthy participants.

ALG-000184 - Aligos Therap

http://www.ncbi.nlm.nih.gov/pubmed/41268712

Christian Schwabe; Ed Gane; John Fry; Kha Le; Lawrence Blatt; Min Wu; Sushmita Chanda; Tse-I Lin

Nov 21, 2025